Levin Capital Strategies’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19,939
| Closed | -$80.4K | – | 258 |
|
|
2023
Q3 | $80.4K | Hold |
19,939
| – | – | 0.01% | 214 |
|
|
2023
Q2 | $143K | Hold |
19,939
| – | – | 0.02% | 214 |
|
|
2023
Q1 | $67K | Hold |
19,939
| – | – | 0.01% | 212 |
|
|
2022
Q4 | $55.2K | Hold |
19,939
| – | – | 0.01% | 215 |
|
|
2022
Q3 | $46K | Hold |
19,939
| – | – | 0.01% | 207 |
|
|
2022
Q2 | $31K | Hold |
19,939
| – | – | ﹤0.01% | 222 |
|
|
2022
Q1 | $97K | Hold |
19,939
| – | – | 0.01% | 243 |
|
|
2021
Q4 | $295K | Hold |
19,939
| – | – | 0.03% | 225 |
|
|
2021
Q3 | $431K | Hold |
19,939
| – | – | 0.04% | 178 |
|
|
2021
Q2 | $327K | Hold |
19,939
| – | – | 0.03% | 207 |
|
|
2021
Q1 | $472K | Buy |
19,939
+578
| +3% | +$13.7K | 0.05% | 149 |
|
|
2020
Q4 | $462K | Hold |
19,361
| – | – | 0.05% | 144 |
|
|
2020
Q3 | $228K | Buy |
19,361
+361
| +2% | +$4.25K | 0.03% | 215 |
|
|
2020
Q2 | $199K | Buy |
19,000
+4,000
| +27% | +$41.9K | 0.03% | 163 |
|
|
2020
Q1 | $107K | Hold |
15,000
| – | – | 0.02% | 156 |
|
|
2019
Q4 | $201K | Hold |
15,000
| – | – | 0.02% | 183 |
|
|
2019
Q3 | $232K | Hold |
15,000
| – | – | 0.03% | 164 |
|
|
2019
Q2 | $198K | Hold |
15,000
| – | – | 0.02% | 184 |
|
|
2019
Q1 | $264K | Hold |
15,000
| – | – | 0.03% | 153 |
|
|
2018
Q4 | $172K | Hold |
15,000
| – | – | ﹤0.01% | 224 |
|
|
2018
Q3 | $213K | Hold |
15,000
| – | – | ﹤0.01% | 240 |
|
|
2018
Q2 | $227K | Hold |
15,000
| – | – | ﹤0.01% | 245 |
|
|
2018
Q1 | $203K | Hold |
15,000
| – | – | ﹤0.01% | 275 |
|
|
2017
Q4 | $354K | Hold |
15,000
| – | – | 0.01% | 222 |
|
|
2017
Q3 | $279K | Buy |
+15,000
| New | +$279K | ﹤0.01% | 266 |
|
|
2017
Q2 | – | Sell |
-10,000
| Closed | -$204K | – | 330 |
|
|
2017
Q1 | $204K | Buy |
+10,000
| New | +$204K | ﹤0.01% | 273 |
|